Ágnes Csontos (Ágnes Milassin)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Cross Sectional

Ultrasound Guided

Top Venues

Expert opinion on biological therapy

Therapeutic advances in gastroenterology

Scandinavian journal of gastroenterology

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Péter Bacsur, Mária Matuz, Tamás Resál, Pál Miheller, Tamás Szamosi, Eszter Schäfer, Patricia Sarlos, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Bálint, Ágnes Csontos, Anna Fábián, Renáta Bor, Zoltán Szepes, Tamás Molnár, Klaudia Farkas
Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study. Therapeutic advances in gastroenterology 15 (2022)
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Csontos, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert opinion on biological therapy 21 (4) (2021)
Péter Kunovszki, Kata Judit Szántó, Judit Gimesi-Országh, Péter Takács, Andras Borsi, Anita Bálint, Klaudia Farkas, Ágnes Csontos, Péter L Lakatos, Tamás Szamosi, Tamás Molnár
Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016. Expert opinion on biological therapy 20 (4) (2020)
Mariann Rutka, Renáta Bor, Tamás Molnár, Klaudia Farkas, Daniella Pigniczki, Anna Fábián, Márk Györffy, Anita Bálint, Ágnes Csontos, Mónika Szücs, László Tiszlavicz, Ferenc Nagy, Zoltán Szepes
Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015 Turkish journal of medical sciences 50 (4) (2020)
Renáta Bor, Béla Vasas, Anna Fábián, Mónika Szücs, Árpád Füredi, László Czakó, Mariann Rutka, Klaudia Farkas, Tamás Molnár, Ágnes Csontos, Anita Bálint, Kata Judit Szántó, Sándor Hamar, László Kaizer, László Tiszlavicz, Zoltán Szepes
Slow-pull technique yields better quality smears: prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine-needle aspiration. Scandinavian journal of gastroenterology 55 (11) (2020)
Renáta Bor, Anna Fábián, Mária Matuz, Zoltán Szepes, Klaudia Farkas, Pál Miheller, Tamás Szamosi, Áron Vincze, Mariann Rutka, Kata Judit Szántó, Anita Bálint, Ferenc Nagy, Ágnes Csontos, Tibor Tóth, Ferenc Zsigmond, Judit Bajor, Katalin Müllner, Lilla Lakner, Mária Papp, Ágnes Salamon, Gábor Horváth, Krisztina Sarang, Eszter Schäfer, Patrícia Sarlós, Károly Palatka, Tamás Molnár
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study. Expert opinion on biological therapy 20 (2) (2019)
Anita Bálint, Mariann Rutka, Martin Kolar, Dana Duricova, Veronika Hruba, Katarina Mitrova, Karin Malickova, Milan Lukas, Zoltán Szepes, Ferenc Nagy, Károly Palatka, Szilvia Lovas, Zsuzsanna Végh, Zsuzsanna Kürti, Ágnes Csontos, Pál Miheller, Tibor Nyári, Renáta Bor, Anna Fábián, Kata Judit Szántó, Péter L Lakatos, Tamás Molnár, Klaudia Farkas
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort. Expert opinion on biological therapy 18 (11) (2018)
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Csontos, Anna Fábián, Kata Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter L Lakatos, Zoltán Szepes, Tamás Molnár
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center. Expert opinion on biological therapy 17 (11) (2017)